Mindfulness-based Stress Reduction Combined With Aerobic Training in Cardiac Rehabilitation After Percutaneous Coronary Intervention: A Dual Impact on Kinesiophobia and Heart Rate Variability
1 other identifier
interventional
150
1 country
1
Brief Summary
To evaluate the effectiveness of mindfulness-based stress reduction (MBSR) combined with aerobic training on treatment adherence, kinesiophobia, heart rate variability (HRV), exercise tolerance, and psychological stress response in patients with coronary heart disease (CHD) post-percutaneous coronary intervention (PCI). Post-PCI patients (n = 150) were randomly assigned to an observation group (receiving combined MBSR and aerobic training) and a control group (receiving aerobic training only). Treatment adherence, the Tampa Scale for Kinesiophobia-Heart (TSK-SV Heart), HRV parameters, exercise tolerance, and psychological stress responses were assessed before and after the intervention. Psychological assessments included the Self-Rating Anxiety Scale (SAS) and the Self-Rating Depression Scale (SDS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2025
CompletedFirst Submitted
Initial submission to the registry
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedApril 22, 2026
April 1, 2026
1.3 years
April 15, 2026
April 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Depression Symptoms
The SDS is a 20-item self-rating scale used to assess the severity of depressive symptoms. Each item is scored on a 4-point Likert scale. Total scores range from 20 to 80. Scores below 53 are considered normal; higher scores indicate more severe depression. The sample size calculation (n=150) was based on an estimated effect size (Cohen's d) of 0.54 for this measure.
Baseline (pre-intervention) and immediately post-intervention (after 8 weeks).
Secondary Outcomes (5)
Change in Anxiety Symptoms
Baseline and post-intervention (8 weeks).
Change in Treatment Adherence Score
Baseline and post-intervention (8 weeks).
Change in Kinesiophobia Level
Baseline and post-intervention (8 weeks).
Change in Standard Deviation of Normal-to-Normal RR Intervals
Baseline and post-intervention (8 weeks).
Change in Standard Deviation of Average Normal-to-Normal RR Intervals in 5-minute Segments
Baseline and post-intervention (8 weeks).
Study Arms (2)
observation group
EXPERIMENTALreceiving combined MBSR and aerobic training
control group
NO INTERVENTIONreceiving aerobic training only
Interventions
Patients participated in 2-hour daily MBSR sessions conducted in a designated hospital rehabilitation room. After discharge, patients were instructed to continue weekly home-based practice for two months. The MBSR components included: (a) Mindful breathing: Conducted in a quiet, comfortable, and distraction-free environment with the patient seated upright, shoulders and neck relaxed. Patients were guided to focus on their breath, feeling the sensation of air flowing in and out, for 10 to 15 minutes per session, 2 to 3 times daily. If thoughts or emotions arose during the session, attention was gently redirected to the breath. (b) Mindfulness meditation: Also performed in a quiet setting, patients were guided to adopt an accepting attitude toward negative emotions without resistance or avoidance. The goal was to allow emotions to arise and naturally dissipate. Each session lasted 20 to 30 minutes, once or twice daily. (c) Body scanning: Patients were guided to assume a comfortable postu
Eligibility Criteria
You may qualify if:
- Confirmed diagnosis of coronary heart disease (CHD)
- Successful percutaneous coronary intervention (PCI) procedure
- No contraindications to rehabilitation exercise
- Provision of written informed consent by the patient and their legal guardian
You may not qualify if:
- Coexisting severe organic disease (e.g., severe valvular disease, advanced kidney or liver failure)
- Malignancy (active or history of cancer within recent years)
- Cognitive impairment (sufficient to preclude understanding or compliance with mindfulness-based stress reduction or exercise instructions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Linyi People's Hospital
Linyi, Shandong, 276000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 22, 2026
Study Start
October 15, 2023
Primary Completion
January 17, 2025
Study Completion
January 25, 2025
Last Updated
April 22, 2026
Record last verified: 2026-04